Cite
HARVARD Citation
Opbroek, T. et al. (2023). BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial. Clinical and translational radiation oncology. pp. 90-95. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Opbroek, T. et al. (2023). BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial. Clinical and translational radiation oncology. pp. 90-95. [Online].